Rescue of lethal c-KitW/W mice by erythropoietin

Blood

Volumn 104, Issue 6, 2004, Pages 1688-1695

  Waskow, Claudia ^a   Terszowski, Grzegorz ^b   Costa, Céline ^b   Gassmann, Max ^b   Rodewald, Hans Reimer ^a  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW HYPOPLASIA; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROPOIESIS; GENE MUTATION; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; MACROCYTIC ANEMIA; MOUSE; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 4444268216     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1247     Document Type: Article

References (49)

1. Bernstein A, Chabot B, Dubreuil P, et al. The mouse W/c-kit locus. Ciba Found Symp. 1990;148:158-166.
2. Besmer P. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr Opin Cell Biol. 1991;3:939-946.
3. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345-1364.
4. Nocka K, Tan JC, Chiu E, et al. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990;9:1805-1813.
5. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 1979;20:357-459.
6. Russell ES, Lawson FA. Selection and inbreeding for longevity of a lethal type. J Hered. 1959;50:19-25.
7. De Aberle SB. A study of the hereditary anaemia of mice. Am J Anat. 1927;40:219-247.
8. Waskow C, Paul S, Haller C, et al. Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity. 2002;17:277-288.
9. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978;52:447-452.
10. Rodewald HR, Ogawa M, Haller C, et al. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity. 1997;6:265-272.
11. McCulloch EA, Siminovitch L, Till JE. Spleen-colony formation in anemic mice of genotype WWv. Science. 1964;144:844-845.
12. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 1991;174:63-71.
13. Ikuta K, Weissman IL. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A. 1992;89:1502-1506.
14. Russell ES, Smith LJ, Lawson FA. Implantation of normal blood-forming tissue in radiated genetically anemic hosts. Science. 1956;124:1076-1077.
15. Mintz B, Fleischman RA. Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta. Proc Natl Acad Sci U S A. 1979;76:5736-5740.
16. Ruschitzka FT, Wenger RH, Stallmach T, et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A. 2000;97:11609-11613.
17. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol. 1988;18:97-104.
18. Sasahara M, Fries JW, Raines EW, et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 1991;64:217-227.
19. Wiessner C, Allegrini PR, Ekatodramis D, et al. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab. 2001;21:857-864.
20. Grimm C, Wenzel A, Stanescu D. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci. 2004;24:5651-5658.
21. Vogel J, Kiessling I, Heinicke K, et al. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood. 2003;102:2278-2284.
22. Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood. 2003;101:4416-4422.
23. Wagner KF, Katschinski DM, Hasegawa J, et al. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood. 2001;97:536-542.
24. De Sepulveda P, Guenet JL, Panthier JJ. Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice. Mol Cell Biol. 1995;15:5898-5905.
25. Fleischman RA. Engraftment of W/c-kit mutant mice is determined by stem cell competition, not by increased marrow "space." Exp Hematol. 1996;24:209-213.
26. Barker JE, Starr E. Characterization of spleen colonies derived from mice with mutations at the W locus. J Cell Physiol. 1991;149:451-458.
27. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med. 2003;228:1-14.
28. Hopfl G, Ogunshola O, Gassmann M. Hypoxia and high altitude: the molecular response. Adv Exp Med Biol. 2003;543:89-115.
29. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7:345-350.
30. Hopfl G, Ogunshola O, Gassmann M. HIFs and tumors-causes and consequences. Am J Physiol Regul Integr Comp Physiol. 2004;286:608-623.
31. Gregory CJ, Eaves AC. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood. 1978;51:527-537.
32. Wu H, Liu X, Jaenisch R, et al. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995;83:59-67.
33. Nocka K, Majumder S, Chabot B, et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 1989;3:816-826.
34. Pharr PN, Hofbauer A, Worthington RE, et al. Residual erythroid progenitors in W/W mice respond to erythropoietin in the absence of steel factor signals. Int J Hematol. 2000;72:178-185.
35. Kina T, Ikuta K, Takayama E, et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000;109:280-287.
36. Keighley GH, Lowy P, Russel ES, et al. Analysis of erythroid homeostatic mechanisms in normal and genetically anaemic mice. Br J Haematol. 1966;12:461-477.
37. Wu H, Klingmuller U, Besmer P, et al. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 1995;377:242-246.
38. Wu H, Klingmuller U, Acurio A, et al. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci U S A. 1997;94:1806-1810.
39. Socolovsky M, Nam H, Fleming MD, et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood. 2001;98:3261-3273.
40. Koury MJ, Sawyer ST, Brandt SJ. New insights into erythropoiesis. Curr Opin Hematol. 2002;9:93-100.
41. Sarvella PA, Russell LB. Steel, a new dominant gene in the house mouse. J Hered. 1956;47:123-128.
42. Chui DH, Liao SK, Walker K. Fetal erythropoiesis in steel mutant mice, III: defect in differentiation from BFU-E to CFU-E during early development. Blood. 1978;51:539-547.
43. Dai CH, Krantz SB, Zsebo KM. Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood. 1991;78:2493-2497.
44. Muta K, Krantz SB, Bondurant MC, et al. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995;86:572-580.
45. Hara H, Ogawa M. Erythropoietic precursors in mice under erythropoietic stimulation and suppression. Exp Hematol. 1977;5:141-148.
46. Cynshi O, Satoh K, Higuchi M, et al. Effects of recombinant human erythropoietin on anaemic W/Wv and Sl/Sld mice. Br J Haematol. 1990;75:319-324.
47. Kabaya K, Akiyama H, Nishi N, et al. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity. Life Sci. 1995;57:1067-1076.
48. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the murine erythropoietin receptor. Cell. 1989;57:277-285.
49. Orlic D, Anderson S, Biesecker LG, et al. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A. 1995;92:4601-4605.